Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2023Research and Practice in Thrombosis and HaemostasisOpen Access

Anticoagulants in frail elderly patients with atrial fibrillation: a delicate balance

View Full Paper
Ask AI
Bookmark
Share

Key result

Severe frailty in older patients with atrial fibrillation initiating anticoagulants was associated with increased bleeding (21.0 vs 11.2 per 100 person-years) but similar ischemic stroke risk.

Why the study?

Does frailty impact the safety and efficacy of oral anticoagulants in elderly patients with atrial fibrillation?

Population

Frail elderly patients with atrial fibrillation

Design

Editorial

Authors

ETEmmy M. Trinks-RoerdinkUtrecht UniversityGeert‐Jan GeersingGeert‐Jan GeersingVascular / Pulmonary Vascular

Discussion

Loading...

Member takes

Implication

Frailty significantly increases bleeding risk without substantially increasing stroke risk in anticoagulated AF patients, underscoring the importance of monitoring rather than withholding anticoagulation.

Key Points

  • Evaluate the clinical balance between stroke prevention and bleeding complications among frail older adults receiving anticoagulation for atrial fibrillation.
  • Analyzed an administrative claims cohort of 12,585 patients aged ≥65 years with nonvalvular atrial fibrillation initiating oral anticoagulants in Japan between 2012 and 2018.
  • Quantified frailty status using the electronic frailty index and assessed clinical endpoints over a median follow-up period of 31 months.
  • Composite bleeding incidence rates nearly doubled from 11.2 per 100 person-years in non-frail patients to 21.0 per 100 person-years in severely frail patients (overall incidence rate: 15.5 per 100 person-years; major bleeding rate: 1.2 per 100 patient-years).
  • Ischemic stroke and transient ischemic attack incidence rates remained remarkably stable across frailty strata, shifting minimally from 1.5 per 100 person-years in non-frail patients to 1.7 per 100 person-years in severely frail patients (overall incidence rate: 1.5 per 100 patient-years).

Structured PICO

Does frailty impact the safety and efficacy of oral anticoagulants in elderly patients with atrial fibrillation?

P
Population
Frail elderly patients with atrial fibrillation
I
Intervention
Oral anticoagulants
O
Outcome
Bleeding and ischemic stroke/transient ischemic attack (TIA)

Main Result

Absolute Event Rate: 21% vs 11.2%

Frailty significantly increases bleeding risk without substantially increasing stroke risk in anticoagulated AF patients, underscoring the importance of monitoring rather than withholding anticoagulation.

Limitations

  • Observational studies on this topic are affected by confounding bias.
  • Frail individuals are often excluded from trial participation.
  • Complexity and heterogeneity of the frailty syndrome hampers direct transferability of inferences.

Cite This Study

Trinks-Roerdink et al. (2023) conducted an editorial in Atrial fibrillation (n=12,585). Severe frailty (exposure) vs. Not frail was evaluated on Composite of major and nonmajor bleeding. Severe frailty in older patients with atrial fibrillation initiating anticoagulants was associated with increased bleeding (21.0 vs 11.2 per 100 person-years) but similar ischemic stroke risk.

synapsesocial.com/papers/6a0f02c69df4132b62f9dc10https://doi.org/10.1016/j.rpth.2023.100199

Topics

Atrial fibrillationAnticoagulation in AFPersistent AF management
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Risk of Bleeding and Thrombosis in Patients 70 Years or Older Using Vitamin K Antagonists2016 · 54 citations
  2. 2Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)2014 · 431 citations
  3. 3New Oral Anticoagulants in Elderly Adults: Evidence from a Meta‐Analysis of Randomized Trials2014 · 267 citations
  4. 4Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation2011 · 1,082 citations
  5. 5Dabigatran versus Warfarin in Patients with Atrial Fibrillation2009 · 11,282 citations